D.E. Shaw & Co’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

D.E. Shaw & Co’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-167,955	Closed	-$1.12M	–	4711
2023 Q3	$1.12M	Buy	167,955 +29,781	+22%	+$248K	﹤0.01%	2992
2023 Q2	$1.25M	Buy	+138,174	New	+$1.22M	﹤0.01%	2949
2022 Q2	–	Sell	-43,744	Closed	-$349K	–	5926
2022 Q1	$349K	Sell	43,744 -39,308	-47%	-$250K	﹤0.01%	4575
2021 Q4	$465K	Buy	83,052 +20,170	+32%	+$151K	﹤0.01%	4445
2021 Q3	$484K	Sell	62,882 -3,400	-5%	-$31K	﹤0.01%	4102
2021 Q2	$681K	Buy	+66,282	New	+$674K	﹤0.01%	3850

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

D.E. Shaw & Co's PNT Position: Q4 2023 in Review

D.E. Shaw & Co sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 167,955 shares — an estimated $1.12M sold.

D.E. Shaw & Co first reported a position in PNT in Q2 2021 and held it in 6 quarters. The position peaked at $1.25M in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

D.E. Shaw & Co reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
D.E. Shaw & Co sold 167,955 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $1.12M.
D.E. Shaw & Co first reported a position in POINT Biopharma Global Inc. Common Stock in Q2 2021 and held it in 6 quarters.
D.E. Shaw & Co's POINT Biopharma Global Inc. Common Stock position peaked at $1.25M in Q2 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.